Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transporter activity	RHCG SLC37A3 SLC16A9 PEX6 PEX12 ASIC3 NDUFA9 CCDC51 SLC7A14 KCNH3 SLC5A4 SLC5A11 SLC7A1 SLC7A3 SCN3A APOL4 SLC39A6 MFSD3	1.26e-04	1289	105	18	GO:0005215
GeneOntologyMolecularFunction	transmembrane transporter activity	RHCG SLC37A3 SLC16A9 PEX12 ASIC3 NDUFA9 CCDC51 SLC7A14 KCNH3 SLC5A4 SLC5A11 SLC7A1 SLC7A3 SCN3A APOL4 SLC39A6 MFSD3	1.37e-04	1180	105	17	GO:0022857
GeneOntologyMolecularFunction	L-ornithine transmembrane transporter activity	SLC7A1 SLC7A3	2.71e-04	5	105	2	GO:0000064
GeneOntologyBiologicalProcess	mesenchyme migration	ACTA1 ACTA2 ACTC1 ACTG2	2.92e-09	5	103	4	GO:0090131
GeneOntologyBiologicalProcess	mesenchyme morphogenesis	ACTA1 ACTA2 ACTC1 ACTG2 HTT	1.83e-05	65	103	5	GO:0072132
Domain	Actin_CS	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.75e-10	16	102	6	IPR004001
Domain	ACTINS_2	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	2.69e-10	17	102	6	PS00432
Domain	Actin/actin-like_CS	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	4.02e-10	18	102	6	IPR020902
Domain	ACTINS_ACT_LIKE	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	5.86e-10	19	102	6	PS01132
Domain	Actin	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.51e-08	31	102	6	IPR004000
Domain	Actin	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.51e-08	31	102	6	PF00022
Domain	ACTIN	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.51e-08	31	102	6	SM00268
Domain	ACTINS_1	ACTA1 ACTA2 ACTC1 ACTG2	5.77e-08	8	102	4	PS00406
Domain	CAT3	SLC7A14 SLC7A1 SLC7A3	1.57e-06	5	102	3	IPR015606
Domain	AA_permease_C	SLC7A14 SLC7A1 SLC7A3	1.57e-06	5	102	3	PF13906
Domain	CAT_C	SLC7A14 SLC7A1 SLC7A3	1.57e-06	5	102	3	IPR029485
Domain	Arp1	ACTR1B ACTR1A	2.95e-05	2	102	2	IPR029909
Domain	CAPS	CADPS CADPS2	2.95e-05	2	102	2	IPR033227
Domain	AA_permease_2	SLC7A14 SLC7A1 SLC7A3	4.35e-05	13	102	3	PF13520
Domain	AA/rel_permease1	SLC7A14 SLC7A1 SLC7A3	4.35e-05	13	102	3	IPR002293
Domain	Cat_AA_permease	SLC7A1 SLC7A3	8.83e-05	3	102	2	IPR004755
Domain	Ifi-6-16	IFI27L2 IFI27	1.76e-04	4	102	2	PF06140
Domain	IFI6/IFI27	IFI27L2 IFI27	1.76e-04	4	102	2	IPR009311
Domain	AA-permease/SLC12A_dom	SLC7A14 SLC7A1 SLC7A3	2.26e-04	22	102	3	IPR004841
Domain	AA_permease	SLC7A14 SLC7A1 SLC7A3	2.26e-04	22	102	3	PF00324
Domain	Hyaluronidase	HYAL4 HYAL2	2.92e-04	5	102	2	IPR018155
Domain	TLE_N	TLE5 TLE2	2.92e-04	5	102	2	PF03920
Domain	Glyco_hydro_56	HYAL4 HYAL2	2.92e-04	5	102	2	PF01630
Domain	DUF1041	CADPS CADPS2	2.92e-04	5	102	2	SM01145
Domain	Groucho/TLE_N	TLE5 TLE2	2.92e-04	5	102	2	IPR005617
Domain	DUF1041	CADPS CADPS2	6.09e-04	7	102	2	PF06292
Domain	Munc13_1	CADPS CADPS2	6.09e-04	7	102	2	IPR014770
Domain	CAPS_dom	CADPS CADPS2	6.09e-04	7	102	2	IPR010439
Domain	MHD1	CADPS CADPS2	6.09e-04	7	102	2	PS51258
Domain	WD40_repeat_dom	MED16 SPAG9 SEC31B PREB TLE2 WDR86 WDFY3	1.22e-03	297	102	7	IPR017986
Domain	NA_SOLUT_SYMP_1	SLC5A4 SLC5A11	1.57e-03	11	102	2	PS00456
Domain	Methyltransf_16	FAM86B1 METTL22	1.57e-03	11	102	2	IPR019410
Domain	Methyltransf_16	FAM86B1 METTL22	1.57e-03	11	102	2	PF10294
Domain	NA_SOLUT_SYMP_2	SLC5A4 SLC5A11	1.88e-03	12	102	2	PS00457
Domain	SSF	SLC5A4 SLC5A11	1.88e-03	12	102	2	PF00474
Domain	Na/solute_symporter	SLC5A4 SLC5A11	1.88e-03	12	102	2	IPR001734
Domain	NA_SOLUT_SYMP_3	SLC5A4 SLC5A11	1.88e-03	12	102	2	PS50283
Domain	-	MED16 SPAG9 SEC31B PREB TLE2 WDR86 WDFY3	2.34e-03	333	102	7	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	MED16 SPAG9 SEC31B PREB TLE2 WDR86 WDFY3	2.42e-03	335	102	7	IPR015943
Domain	WD40	MED16 SEC31B PREB TLE2 WDR86 WDFY3	2.98e-03	259	102	6	PF00400
Domain	Quinoprotein_ADH-like_supfam	AHCTF1 PREB WDR86	3.04e-03	53	102	3	IPR011047
Domain	WD40	MED16 SEC31B PREB TLE2 WDR86 WDFY3	3.52e-03	268	102	6	SM00320
Domain	WD40_repeat	MED16 SEC31B PREB TLE2 WDR86 WDFY3	3.79e-03	272	102	6	IPR001680
Domain	WD_REPEATS_1	MED16 SEC31B PREB TLE2 WDR86 WDFY3	4.21e-03	278	102	6	PS00678
Domain	WD_REPEATS_2	MED16 SEC31B PREB TLE2 WDR86 WDFY3	4.29e-03	279	102	6	PS50082
Domain	WD_REPEATS_REGION	MED16 SEC31B PREB TLE2 WDR86 WDFY3	4.29e-03	279	102	6	PS50294
Pubmed	Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	9971772
Pubmed	Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	10074138
Pubmed	Virus assembly and plasma membrane domains: which came first?	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	22989508
Pubmed	HIV-1 protease cleaves actin during acute infection of human T-lymphocytes.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	1540415
Pubmed	HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	11709093
Pubmed	Tagging the human immunodeficiency virus gag protein with green fluorescent protein. Minimal evidence for colocalisation with actin.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	10049817
Pubmed	Human immunodeficiency virus nucleocapsid protein polymorphisms modulate the infectivity of RNA packaging mutants.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	12009869
Pubmed	HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	23811015
Pubmed	Retroviral assembly and budding occur through an actin-driven mechanism.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	19883584
Pubmed	Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	21917091
Pubmed	HIV-1 Gag protein associates with F-actin present in microfilaments.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	8661406
Pubmed	A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	23017337
Pubmed	Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	23875777
Pubmed	Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton.	ACTA1 ACTA2 ACTC1 ACTG2	1.22e-09	6	106	4	9841925
Pubmed	The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry.	ACTA1 ACTA2 ACTC1 ACTG2	2.83e-09	7	106	4	22535526
Pubmed	Selective targeting of ITK blocks multiple steps of HIV replication.	ACTA1 ACTA2 ACTC1 ACTG2	2.83e-09	7	106	4	18443296
Pubmed	The trinity of the cortical actin in the initiation of HIV-1 infection.	ACTA1 ACTA2 ACTC1 ACTG2	2.83e-09	7	106	4	22640593
Pubmed	HIV-1 replication from after cell entry to the nuclear periphery.	ACTA1 ACTA2 ACTC1 ACTG2	2.83e-09	7	106	4	17504171
Pubmed	siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.	ACTA1 ACTA2 ACTC1 ACTG2	2.83e-09	7	106	4	22465675
Pubmed	Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production.	ACTA1 ACTA2 ACTC1 ACTG2	5.65e-09	8	106	4	14694110
Pubmed	Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling.	ACTA1 ACTA2 ACTC1 ACTG2	5.65e-09	8	106	4	20147394
Pubmed	Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organization.	ACTA1 ACTA2 ACTC1 ACTG2	5.65e-09	8	106	4	23260110
Pubmed	Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF.	ACTA1 ACTA2 ACTC1 ACTG2	1.01e-08	9	106	4	10556093
Pubmed	Cytoskeletal proteins inside human immunodeficiency virus type 1 virions.	ACTA1 ACTA2 ACTC1 ACTG2	1.01e-08	9	106	4	8892894
Pubmed	HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells.	ACTA1 ACTA2 ACTC1 ACTG2	1.01e-08	9	106	4	18775311
Pubmed	Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus.	ACTA1 ACTA2 ACTC1 ACTG2	1.69e-08	10	106	4	1907279
Pubmed	Non-viral cellular substrates for human immunodeficiency virus type 1 protease.	ACTA1 ACTA2 ACTC1 ACTG2	1.69e-08	10	106	4	1991513
Pubmed	Gelsolin activity controls efficient early HIV-1 infection.	ACTA1 ACTA2 ACTC1 ACTG2	1.69e-08	10	106	4	23575248
Pubmed	CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function.	ACTA1 ACTA2 ACTC1 ACTG2	2.65e-08	11	106	4	30962377
Pubmed	N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton.	ACTA1 ACTA2 ACTC1 ACTG2	2.65e-08	11	106	4	23294842
Pubmed	Quantitative proteomic analysis of lentiviral vectors using 2-DE.	ACTA1 ACTA2 ACTC1 ACTG2	2.65e-08	11	106	4	19639585
Pubmed	Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization.	ACTA1 ACTA2 ACTC1	2.75e-08	3	106	3	7780165
Pubmed	HIV-1 Nef impairs heterotrimeric G-protein signaling by targeting Gα(i2) for degradation through ubiquitination.	ACTA1 ACTA2 ACTC1 ACTG2	3.96e-08	12	106	4	23071112
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	HYAL4 CAD AHCTF1 ACTA1 ACTA2 ACTC1 ACTG2 ACTR1A SEPHS2 CADPS ACAN HSD17B10	5.86e-08	513	106	12	25798074
Pubmed	LIM kinase 1 - dependent cofilin 1 pathway and actin dynamics mediate nuclear retinoid receptor function in T lymphocytes.	ACTA1 ACTA2 ACTC1 ACTG2	7.97e-08	14	106	4	21923909
Pubmed	Regulating the functions of the HIV-1 matrix protein.	ACTA1 ACTA2 ACTC1 ACTG2	7.97e-08	14	106	4	17411366
Pubmed	Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1.	ACTA1 ACTA2 ACTC1 ACTG2	1.88e-07	17	106	4	17360745
Pubmed	The cleavage of host cell proteins by HIV-1 protease.	ACTA1 ACTA2 ACTC1 ACTG2	1.88e-07	17	106	4	8997639
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	ACTA1 ACTA2 ACTC1 ACTG2 NDUFA9 DDOST TMEM263 PREB SLC7A1 AP1B1 PI4KB SLC39A6 HSD17B10 HSPA5 EPB41L2	2.08e-07	952	106	15	38569033
Pubmed	Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis.	ACTA1 ACTA2 ACTC1 PRKAR1A	3.05e-07	19	106	4	18316483
Pubmed	Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression.	ACTA1 ACTA2 ACTC1 ACTG2	5.72e-07	22	106	4	16526095
Pubmed	Essential and supporting host cell factors for HIV-1 budding.	ACTA1 ACTA2 ACTC1 ACTG2	6.90e-07	23	106	4	22004035
Pubmed	Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.	ACTA1 ACTA2 ACTC1	9.55e-07	7	106	3	9384381
Pubmed	A Novel Mouse Model for Cilia-Associated Cardiovascular Anomalies with a High Penetrance of Total Anomalous Pulmonary Venous Return.	ACTA1 ACTA2 ACTC1	9.55e-07	7	106	3	30289203
Pubmed	Interactions between the evolutionarily conserved, actin-related protein, Arp11, actin, and Arp1.	ACTA1 ACTR1B ACTR1A	9.55e-07	7	106	3	12857853
Pubmed	Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.	ACTA1 ACTA2 ACTC1 ACTG2	1.16e-06	26	106	4	24742657
Pubmed	Endogenously nitrated proteins in mouse brain: links to neurodegenerative disease.	PREB ACTR1B AP1B1 HSPA5	1.36e-06	27	106	4	16800626
Pubmed	Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies.	ACTA1 ACTA2 ACTC1	1.52e-06	8	106	3	20096780
Pubmed	Sox4-deficiency syndrome in mice is an animal model for common trunk.	SOX4 ACTA2 ACTC1	1.52e-06	8	106	3	9815146
Pubmed	LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.	FLNB CAD MYO18A ACTC1 PFKM NDUFA9 DDOST ACTR1A HSD17B10 HSPA5 EPB41L2	1.68e-06	580	106	11	35676659
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	FLNB ACTA2 ACTC1 PSMC5 PFKM SRCAP ACTR1A SEPHS2 AP1B1 PRKAR1A HSD17B10 HSPA5 EPB41L2	1.92e-06	847	106	13	35235311
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	FLNB ACTA1 PSMC5 SPAG9 PFKM CBS ACTR1B ACTR1A AP1B1 TLE5 PRKAR1A HSD17B10 COASY FH HSPA5 EPB41L2 HTT	1.93e-06	1455	106	17	22863883
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	FLNB ACTA1 MYO18A ACTC1 HSD17B10 FH HSPA5	2.08e-06	191	106	7	33762435
Pubmed	Modulation of cardiac growth and development by HOP, an unusual homeodomain protein.	ACTA1 ACTA2 ACTC1	2.28e-06	9	106	3	12297046
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	CAD AHCTF1 MPDZ PSMC5 PFKM CCDC51 TLE5 COASY	2.64e-06	283	106	8	18854154
Pubmed	The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse.	ACTA1 ACTA2 ACTC1 ACTG2	2.74e-06	32	106	4	23369715
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	MYO18A PSMC5 PFKM NDUFA9 DDOST ACTR1B AP1B1 HSD17B10 HSPA5 EPB41L2 HTT	3.23e-06	621	106	11	22794259
Pubmed	Interaction of c-Cbl with myosin IIA regulates Bleb associated macropinocytosis of Kaposi's sarcoma-associated herpesvirus.	ACTA1 ACTG2 HSPA5	3.25e-06	10	106	3	21203488
Pubmed	Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease.	ACTA1 ACTA2 ACTC1	3.25e-06	10	106	3	21749862
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	FLNB CAD PSMC5 SPAG9 CBS DDOST ACTR1A AP1B1 HSD17B10 HSPA5 EPB41L2	4.18e-06	638	106	11	33239621
Pubmed	FRS2α-mediated FGF signals suppress premature differentiation of cardiac stem cells through regulating autophagy activity.	ACTA1 ACTA2 ACTC1	4.46e-06	11	106	3	22207710
Pubmed	SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice.	ACTA1 ACTA2 ACTC1	5.93e-06	12	106	3	31042497
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	FLNB ACTA1 ACTA2 PSMC5 BCOR NDUFA9 ACTR1B ACTR1A AP1B1 PRKAR1A FH	6.18e-06	665	106	11	30457570
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	FLNB CAD SPOCK1 MUC19 SRCAP NDUFA9 DDOST ACTR1A AP1B1 HSD17B10 FH HSPA5	6.73e-06	807	106	12	30575818
Pubmed	Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice.	ACTA1 ACTA2 ACTC1	7.70e-06	13	106	3	18400219
Pubmed	CAPS1 and CAPS2 regulate stability and recruitment of insulin granules in mouse pancreatic beta cells.	CADPS CADPS2	9.20e-06	2	106	2	18177725
Pubmed	Characterization of two ENU-induced mutations affecting mouse skeletal morphology.	FLNB NPR3	9.20e-06	2	106	2	23979929
Pubmed	Investigation of changes in skeletal muscle alpha-actin expression in normal and pathological human and mouse hearts.	ACTA1 ACTC1	9.20e-06	2	106	2	20706863
Pubmed	Beta-centractin: characterization and distribution of a new member of the centractin family of actin-related proteins.	ACTR1B ACTR1A	9.20e-06	2	106	2	7696711
Pubmed	A 5' duplication of the alpha-cardiac actin gene in BALB/c mice is associated with abnormal levels of alpha-cardiac and alpha-skeletal actin mRNAs in adult cardiac tissue.	ACTA1 ACTC1	9.20e-06	2	106	2	3023046
Pubmed	Huntingtin interacts with cystathionine beta-synthase.	CBS HTT	9.20e-06	2	106	2	9466992
Pubmed	Azilsartan prevented AGE-induced inflammatory response and degradation of aggrecan in human chondrocytes through inhibition of Sox4.	SOX4 ACAN	9.20e-06	2	106	2	34051020
Pubmed	Misfolding of proteins with a polyglutamine expansion is facilitated by proteasomal chaperones.	PSMC5 HTT	9.20e-06	2	106	2	18986984
Pubmed	CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins.	CADPS CADPS2	9.20e-06	2	106	2	18022372
Pubmed	CAPS-1 requires its C2, PH, MHD1 and DCV domains for dense core vesicle exocytosis in mammalian CNS neurons.	CADPS CADPS2	9.20e-06	2	106	2	28883501
Pubmed	Transcripts of alpha-cardiac and alpha-skeletal actins are early markers for myogenesis in the mouse embryo.	ACTA1 ACTC1	9.20e-06	2	106	2	3075543
Pubmed	Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin.	ACTC1 ACTG2	9.20e-06	2	106	2	9114002
Pubmed	Two distinct secretory vesicle-priming steps in adrenal chromaffin cells.	CADPS CADPS2	9.20e-06	2	106	2	20855507
Pubmed	Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin.	ACTA1 ACTC1	9.20e-06	2	106	2	19468071
Pubmed	CAPS facilitates filling of the rapidly releasable pool of large dense-core vesicles.	CADPS CADPS2	9.20e-06	2	106	2	18495893
Pubmed	Increased Cat3-mediated cationic amino acid transport functionally compensates in Cat1 knockout cell lines.	SLC7A1 SLC7A3	9.20e-06	2	106	2	9614060
Pubmed	Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4.	SOX4 ACTA2	9.20e-06	2	106	2	8614465
Pubmed	The localization and interactions of huntingtin.	CBS HTT	9.20e-06	2	106	2	10434301
Pubmed	alpha-Actin proteins and gene transcripts are colocalized in embryonic mouse muscle.	ACTA1 ACTC1	9.20e-06	2	106	2	1893870
Pubmed	Muscle specific expression of Cre recombinase under two actin promoters in transgenic mice.	ACTA2 ACTC1	9.20e-06	2	106	2	10686609
Pubmed	CAPS-1 promotes fusion competence of stationary dense-core vesicles in presynaptic terminals of mammalian neurons.	CADPS CADPS2	9.20e-06	2	106	2	25719439
Pubmed	Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues.	SLC7A1 SLC7A3	9.20e-06	2	106	2	11591158
Pubmed	A developmental study of the abnormal expression of alpha-cardiac and alpha-skeletal actins in the striated muscle of a mutant mouse.	ACTA1 ACTC1	9.20e-06	2	106	2	2731651
Pubmed	A fetal skeletal muscle actin mRNA in the mouse and its identity with cardiac actin mRNA.	ACTA1 ACTC1	9.20e-06	2	106	2	6897014
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	FLNB CAD ACTA2 MYO18A ACTC1 MPDZ PSMC5 SPAG9 ACTR1A AP1B1 PRKAR1A HSD17B10 HSPA5 EPB41L2	1.07e-05	1149	106	14	35446349
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	EMC6 CAD AHCTF1 MYO18A MPDZ PFKM NDUFA9 DDOST TMEM263 PREB PRKAR1A SLC39A6 HSD17B10 COASY HSPA5 EPB41L2	1.12e-05	1487	106	16	33957083
Pubmed	Discovery of a Human Testis-specific Protein Complex TEX101-DPEP3 and Selection of Its Disrupting Antibodies.	FLNB ACTA1 PSMC5 DDOST ACTR1A FH HSPA5	1.18e-05	249	106	7	30097533
Pubmed	LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool.	ACTA2 AP1B1 CADPS	1.22e-05	15	106	3	21307259
Pubmed	Severe protein aggregate myopathy in a knockout mouse model points to an essential role of cofilin2 in sarcomeric actin exchange and muscle maintenance.	ACTA1 ACTA2 ACTC1	1.22e-05	15	106	3	24598388
Pubmed	Extraocular muscle morphogenesis and gene expression are regulated by Pitx2 gene dose.	ACTA1 ACTA2 ACTC1	1.50e-05	16	106	3	16638982
Pubmed	Serum response factor is essential for mesoderm formation during mouse embryogenesis.	ACTA1 ACTA2 ACTC1	1.50e-05	16	106	3	9799237
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	FLNB CAD AHCTF1 PSMC5 PFKM SRCAP NDUFA9 TEX10 DDOST ACTR1B ACTR1A GTF2H4 WDFY3 HSPA5 EPB41L2	1.53e-05	1353	106	15	29467282
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	FLNB MUC19 SPAG9 ITGAE ATXN1L DDOST TMEM260 SCN3A PKHD1 HSPA5 EPB41L2	1.59e-05	736	106	11	29676528
Pubmed	Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions.	NDUFA9 ACTR1B ACTR1A AP1B1 HSPA5 EPB41L2	1.73e-05	176	106	6	18614564
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	EMC6 MED16 AHCTF1 PSMC5 PEX12 NDUFA9 TEX10 DDOST PREB SLC7A1 GTF2H4 SLC39A6 HSPA5 SLX4	1.78e-05	1203	106	14	29180619
Interaction	ACTG1 interactions	FLNB CAD ACTA1 ACTA2 MYO18A ACTC1 ACTG2 SRCAP ACTR1B ACTR1A HSPA5 SLX4 HTT	3.10e-06	520	105	13	int:ACTG1
Interaction	ACTA1 interactions	ACTA1 ACTA2 MYO18A ACTC1 ACTG2 ACTR1B PRKAR1A COASY HSPA5 EPB41L2 HTT	3.77e-06	371	105	11	int:ACTA1
Interaction	CCT8 interactions	FLNB CAD ACTC1 PSMC5 SEC31B ACTR1A TLE2 PRKAR1A HSD17B10 WDR86 HSPA5 SLX4 HTT	5.70e-06	550	105	13	int:CCT8
Interaction	TNNI3 interactions	SOX4 ACTA1 ACTA2 PSMC5	1.29e-05	28	105	4	int:TNNI3
Interaction	PDCL3 interactions	ACTA2 ACTC1 PTER ACTR1B ACTR1A WDR86	1.39e-05	100	105	6	int:PDCL3
Interaction	MYL1 interactions	ACTA1 ACTA2 TMEM260 HSD17B10 HSPA5	1.78e-05	62	105	5	int:MYL1
Interaction	POTEI interactions	ACTA1 ACTA2 OSER1 ACTC1 ACTG2 EPB41L2	1.84e-05	105	105	6	int:POTEI
Interaction	CCT5 interactions	ACTA1 ACTA2 ACTC1 SEC31B ACTR1B ACTR1A TLE2 PRKAR1A WDR86 SLX4 EPB41L2 HTT	1.87e-05	525	105	12	int:CCT5
Interaction	HLX interactions	ACTA1 ATXN1L TLE5 TLE2	4.03e-05	37	105	4	int:HLX
Interaction	NEK4 interactions	HYAL4 CAD AHCTF1 ACTA1 ACTA2 ACTC1 ACTG2 ACTR1A SEPHS2 CADPS ACAN HSD17B10	5.09e-05	582	105	12	int:NEK4
Interaction	TPM1 interactions	ACTA2 MYO18A ACTC1 PSMC5 SPAG9 CBS ACTR1A HTT	7.08e-05	263	105	8	int:TPM1
Interaction	PRDM1 interactions	BCOR ATXN1L TLE5 TLE2 HSPA5	7.77e-05	84	105	5	int:PRDM1
Interaction	CCT4 interactions	CAD ACTA1 ACTA2 ACTC1 SEC31B ACTR1B ACTR1A TLE2 WDR86 SLX4 HTT	7.80e-05	515	105	11	int:CCT4
Interaction	PLEC interactions	AHCTF1 ACTA1 ACTA2 MYO18A ACTC1 ACTG2 URGCP ACTR1A HSPA5 HTT	8.35e-05	430	105	10	int:PLEC
Interaction	EPS15L1 interactions	SOX4 SPAG9 FCHO1 AP1B1 HSPA5 HTT	8.53e-05	138	105	6	int:EPS15L1
Interaction	CCT6B interactions	ACTC1 SEC31B ACTR1B ACTR1A TLE2 WDR86 HTT	1.06e-04	207	105	7	int:CCT6B
Interaction	FGD5 interactions	FLNB ACTA1 MYO18A ACTC1 HSD17B10 FH HSPA5	1.06e-04	207	105	7	int:FGD5
Interaction	MYH10 interactions	NRF1 ACTA2 ACTC1 ACTG2 PSMC5 SPAG9 ACTR1A HSPA5 HTT	1.09e-04	359	105	9	int:MYH10
Interaction	GSN interactions	ACTA1 ACTA2 MYO18A ACTC1 ACTR1B ACTR1A HTT	1.23e-04	212	105	7	int:GSN
Interaction	ACTG2 interactions	ACTA1 ACTA2 ACTC1 ACTG2	1.23e-04	49	105	4	int:ACTG2
Interaction	LRRC20 interactions	ACTA2 ACTC1 HSPA5	1.25e-04	19	105	3	int:LRRC20
Interaction	DHFR2 interactions	CAD PSMC5 ADGRV1 PFKM PREB TMEM25 SLC39A6 HSPA5	1.36e-04	289	105	8	int:DHFR2
Interaction	POTEJ interactions	ACTA1 ACTA2 ACTC1 ACTG2	1.55e-04	52	105	4	int:POTEJ
Interaction	CFL1 interactions	SOX4 ACTA1 ACTA2 MYO18A ACTC1 ACTG2 PRKAR1A HSPA5 SLX4	1.81e-04	384	105	9	int:CFL1
Interaction	MGAT5 interactions	SLC7A14 TMEM25 SLC7A1 HSPA5	1.93e-04	55	105	4	int:MGAT5
Cytoband	19p13.3	MED16 DENND1C TLE5 TLE2 GZMM	2.33e-04	237	106	5	19p13.3
Cytoband	7q31.3	HYAL4 CADPS2	5.44e-04	15	106	2	7q31.3
GeneFamily	Actins	ACTA1 ACTA2 ACTC1 ACTG2	2.13e-09	6	64	4	929
GeneFamily	Solute carriers	RHCG SLC37A3 SLC16A9 SLC7A14 SLC5A4 SLC5A11 SLC7A1 SLC7A3 SLC39A6	9.86e-06	395	64	9	752
GeneFamily	WD repeat domain containing	MED16 SEC31B PREB TLE2 WDR86 WDFY3	3.24e-04	262	64	6	362
GeneFamily	AAA ATPases\|Peroxins	PEX6 PEX12	1.43e-03	16	64	2	957
GeneFamily	PDZ domain containing	FRMPD2 MYO18A MPDZ GRIP2	2.06e-03	152	64	4	1220
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	NPR3 DENND1C	3.51e-03	25	64	2	504
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_100	ACTA1 ACTA2 ACTC1 ACTG2	7.76e-06	26	105	4	gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_100	ACTA1 ACTA2 ACTC1 ACTG2	1.05e-05	28	105	4	gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500	ACTA2 ACTC1 ACTG2 PNISR PTER TMEM263 CADPS SCN3A CADPS2 EPB41L2	2.54e-05	393	105	10	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_100	ACTA2 ACTC1 ACTG2	5.12e-05	15	105	3	gudmap_developingLowerUrinaryTract_P1_ureter_100_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#5_top-relative-expression-ranked_200	ACTA1 ACTC1 ACTG2	7.60e-05	17	105	3	gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_200_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_500	ACTA1 ACTA2 ACTC1 ACTG2	9.29e-05	48	105	4	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k4
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000	ACTA1 ACTA2 ACTC1 ACTG2 DDOST ACAN GRIP2 WDFY3	1.05e-04	293	105	8	gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_100	ACTA1 ACTA2 ACTG2	1.07e-04	19	105	3	gudmap_developingLowerUrinaryTract_adult_bladder_100_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_200	ACTA1 ACTA2 ACTC1 ACTG2	1.09e-04	50	105	4	gudmap_developingLowerUrinaryTract_P1_bladder_B_200_k2
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000	RHCG SGMS2 NPR3 ACTA1 ACTA2 ACTC1 ACTG2 PTER DDOST ACAN PKHD1 GRIP2 WDFY3 PLCE1	1.47e-04	905	105	14	gudmap_kidney_P0_JuxtaGlom_Ren1_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_200	ACTA2 ACTC1 ACTG2 TMEM263 CADPS EPB41L2	1.66e-04	164	105	6	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB CAD PREB AP1B1 CADPS ENTPD3 HSPA5	4.08e-07	193	106	7	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA2 ACTC1 ACTG2 ACAN ENTPD3 PLCE1	1.74e-06	152	106	6	bd1f36b436d8ab7dd8420f595b97d851eab31a38
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA2 ACTC1 ACTG2 ACAN ENTPD3 PLCE1	1.74e-06	152	106	6	ee329249a034a969a16b26a224aa04249d67382d
ToppCell	368C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ACTG2 ADGRV1 IFI27 FCSK CADPS2 PLCE1	3.44e-06	171	106	6	e59afa0a773dca3b9c208d17510ea55703b42598
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 SLC16A9 MUC19 ADGRV1 PTER SLC5A11	5.08e-06	183	106	6	d73cac83cde82665f110baad7cf28db75f9ffe52
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	FLNB NPR3 BCOR IFI27 CADPS2 HYAL2	5.75e-06	187	106	6	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	SOX4 ACTG2 TSC22D2 TLE5 TLE2 GRIP2	6.30e-06	190	106	6	842760bfe0a52e67bad800efa7d99448a4a23ebb
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 ACAN SCN3A GRIP2 PLCE1	6.49e-06	191	106	6	5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 ACAN SCN3A GRIP2 PLCE1	6.69e-06	192	106	6	eb9a0b3d32f90f8b95905c740aab21639dae5cbd
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTC1 ACTG2 ACAN GRIP2 PLCE1	6.89e-06	193	106	6	469a7f1c2ff7137cc5a064464456911f67f92e70
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTC1 ACTG2 ACAN GRIP2 PLCE1	6.89e-06	193	106	6	323d1f3f4fbeb93ba857fc135d8aa0b897f98ac5
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NPR3 ACTA2 ACTG2 CADPS ACAN PLCE1	6.89e-06	193	106	6	ba6eb29478d16589172f48f9992e5116328c81d6
ToppCell	Bronchial_Biopsy-Mesenchymal-Smooth_muscle\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	ACTA2 ACAN SCN3A ENTPD3 GRIP2 PLCE1	7.74e-06	197	106	6	98f0184a09563a544f0c2d4df22c9db2fbc95019
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ACTA1 ACTA2 ACTC1 ACTG2 SCN3A GRIP2	7.74e-06	197	106	6	b67ffd27d386c8186ef71ecdac96a462504507f0
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX4 NPR3 BEND4 TMEM263 HSPA5 EPB41L2	8.20e-06	199	106	6	08bdcabc3fce787578a8eb66fc8412b0974fa6cc
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA2 ACAN SCN3A ENTPD3 PLCE1	3.17e-05	152	106	5	0cb5f4dfae04e3f4eba502bbf229007d5fa3884d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA2 ACAN SCN3A ENTPD3 PLCE1	3.17e-05	152	106	5	ba89ffb5a8bb33c188f854f54b39123b6d73496a
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRF1 MATN1 TEX10 FCHO1 TTBK1	4.43e-05	163	106	5	4af92b211d12c5b88b65bb746242cd702b545bd0
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRF1 MATN1 TEX10 FCHO1 TTBK1	4.43e-05	163	106	5	d24774e0aa612322c22fdb3b314aef275fa01d68
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTC1 ACTG2 GRIP2 PLCE1	4.97e-05	167	106	5	784776d1fcc098f84d3c2eca58fa56cb9428f434
ToppCell	systemic_lupus_erythematosus-treated-Hematopoietic\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SOX4 DCHS2 NPR3 SLC7A3 TLE5	5.41e-05	170	106	5	9a18756e6721980d4b6c37bb52ddfe93ca79c5ab
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DENND1C TEX10 FCHO1 TTBK1 METTL22	5.41e-05	170	106	5	bda900c836e0f2c1d7b442beb50b672d025b2420
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACTA2 ACTC1 ACTG2 ACAN GRIP2	5.56e-05	171	106	5	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	ACTA2 ACTG2 ACAN SCN3A PLCE1	5.56e-05	171	106	5	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 TMEM25 SCN3A GRIP2 PLCE1	6.04e-05	174	106	5	197686570cec6d96a92e77e6409325d3bfe6f991
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTG2 ACAN GRIP2 PLCE1	6.04e-05	174	106	5	41eb0a214a8b4015a26311f77061c8147144f0e7
ToppCell	facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 TMEM25 SCN3A GRIP2 PLCE1	6.04e-05	174	106	5	2eee7b5471672b439f95eba11494c2adf8cb7006
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADGRV1 SLC7A14 CADPS SCN3A GRIP2	6.04e-05	174	106	5	a62531ebf16b32b249168dca11b870f63a8aa81c
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 SCN3A GRIP2 PLCE1	6.20e-05	175	106	5	d8e385320f554d974538b7cdc4f8e4767f1455f2
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 SCN3A GRIP2 PLCE1	6.20e-05	175	106	5	cf15465855602ba135752c18755e3e058dbd42ec
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTA2 ACTC1 ACAN ENTPD3 GRIP2	6.37e-05	176	106	5	90f36f10c6ed440a0ca549f23219398853f1fbc3
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	DCHS2 ACTA2 ACTG2 ACAN GRIP2	6.37e-05	176	106	5	2015539c58aa0bb118e111ffedd63dd9fe863bb1
ToppCell	droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 KCNH3 SCN3A GRIP2	6.55e-05	177	106	5	dbdbdc8ed9ef0b529694242ef9f9f07a42e16005
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTA2 ACTG2 ACAN ENTPD3 GRIP2	6.55e-05	177	106	5	d731400997afea379f47ae8aa0f82802962b0861
ToppCell	droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 KCNH3 SCN3A GRIP2	6.72e-05	178	106	5	416f85e51f45ec7949451fd47611a84e33e87245
ToppCell	facs-Heart-RA-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 SCN3A GRIP2 PLCE1	6.90e-05	179	106	5	d76a05f1fee7f2f7b7b7994d3622e96f02b49432
ToppCell	facs-Heart-RA-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 SCN3A GRIP2 PLCE1	6.90e-05	179	106	5	6be47c877250968a916c711ba0787eb7b4c5443d
ToppCell	facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 WDR86 GRIP2 PLCE1	7.09e-05	180	106	5	0059e5acade6c895fd629767bea1c15f40b0d1b0
ToppCell	Bronchial_Biopsy-Mesenchymal-Smooth_muscle\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	ACTA2 ACTG2 ACAN SCN3A GRIP2	7.09e-05	180	106	5	7085a851807e6a833965e1366946db0bbc5174e2
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPR3 SPOCK1 MS4A2 ENTPD3 PLCE1	7.09e-05	180	106	5	35c73670da90cb6924e822a2426d13a675685f09
ToppCell	facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 WDR86 GRIP2 PLCE1	7.09e-05	180	106	5	dfb8412e1e06fa7349e66eea2ef27d9ea98b7893
ToppCell	Pericytes-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	FLNB DCHS2 SPOCK1 ACTA2 ACAN	7.27e-05	181	106	5	35c470988a93381eefa300831aabb813fa1b90bd
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T\|lymph-node_spleen / Manually curated celltypes from each tissue	SOX4 NPR3 MPDZ FAAH PLEKHG4B	7.66e-05	183	106	5	6c55fd737ed31f5b1aa41dc4dba7240521c19022
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN1 ACTA2 ACTC1 ACTG2 PFKM	7.66e-05	183	106	5	6f5dbac2748f50105f0f548d189c42ef14287019
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-3\|World / Primary Cells by Cluster	SOX4 IFI27L2 BEND4 APOL4 GRIP2	7.86e-05	184	106	5	907ba412166bcb0526c5be0b06a76b6bd37c5a35
ToppCell	facs-Heart-RA-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 TTBK1 SCN3A WDR86	8.06e-05	185	106	5	c4ef8d9f8b9769e887daac4efd9dc05738b28ae2
ToppCell	droplet-Heart-4Chambers-21m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTER SCN3A GZMM METTL22 PLCE1	8.06e-05	185	106	5	bb5a4cf93534b9bcd0923f314c389d571e91e7f8
ToppCell	facs-Heart-RA-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 TTBK1 SCN3A WDR86	8.06e-05	185	106	5	10ddf38d908525b4258f9d2da8be4c56ebc08ff4
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SGMS2 PTER PLEKHG4B PKHD1 CADPS2	8.27e-05	186	106	5	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	3'_v3-blood-Hematopoietic_progenitors-Progenitor_Erythro-Mega\|blood / Manually curated celltypes from each tissue	SOX4 NPR3 SLC16A9 MPDZ BEND4	8.27e-05	186	106	5	59c115bbbb4bca4ad80be1809d8a0422b8438ea3
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACTA2 ACTC1 ACTG2 ACAN PLCE1	8.27e-05	186	106	5	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 WDR86 GRIP2 PLCE1	8.48e-05	187	106	5	dba4924d914a7dcd4901142684ba920c2404860b
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 WDR86 GRIP2 PLCE1	8.48e-05	187	106	5	9688141beef4f62613d7a810c5872ccb9afc1a71
ToppCell	facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 SCN3A GRIP2 PLCE1	8.48e-05	187	106	5	f1e9877d859369b862d4a559ec9ab9be74a67a96
ToppCell	facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 SCN3A GRIP2 PLCE1	8.48e-05	187	106	5	3ffbd50b49059dcd3e23c5ac01901e4352142446
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	FRMPD2 ACTC1 CADPS GRIP2 PLCE1	8.70e-05	188	106	5	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RHCG SLC16A9 ACTA2 ACTG2 HSPA5	8.70e-05	188	106	5	c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RHCG SOX4 ACTA2 ACTC1 ACTG2	8.70e-05	188	106	5	4d1e5f85342ae550086609d7680e32730b78b5d2
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	BEND4 SLC7A3 CADPS SCN3A GRIP2	8.70e-05	188	106	5	b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 KCNH3 SCN3A PLCE1	8.92e-05	189	106	5	de51fbd6fdb24fc4549393cf41a020005444b2aa
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACTA2 ACTC1 ACTG2 ACAN PLCE1	8.92e-05	189	106	5	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	ACTA2 ACTG2 IFI27 ACAN PLCE1	8.92e-05	189	106	5	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ACTA2 ACTC1 ACTG2 GRIP2 PLCE1	8.92e-05	189	106	5	b5439ef221106f6d54434f268485e9bb17b39102
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	RHCG ACTA2 ACTG2 CADPS TLE2	8.92e-05	189	106	5	0abc7a4900cc9033bc1be69b770ccc54a6bf41b4
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACTA2 ACTC1 ACTG2 ACAN PLCE1	9.14e-05	190	106	5	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACTC1 TLE2 ENTPD3 GRIP2 PLCE1	9.14e-05	190	106	5	8c9c230a509afaeee50644153974a5642b01a2b8
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron\|World / Primary Cells by Cluster	SOX4 IFI27L2 BEND4 APOL4 GRIP2	9.37e-05	191	106	5	4dd9c8117c4499ed9bde127baf2598603a82080d
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-arterial_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MUC19 IFI27 APOL4 GRIP2 HYAL2	9.37e-05	191	106	5	0b022d8b39eac36115b269aac11a5eaa492754cc
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA1 ACTA2 ACTG2 PFKM SCN3A	9.37e-05	191	106	5	f932980baa032748857cb367a55c37dd975c693e
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPR3 ACTA2 ACTG2 ENTPD3 GRIP2	9.60e-05	192	106	5	7aadc7c5bd03274f9861dde2febda5c37f8afc9c
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1\|World / Primary Cells by Cluster	SOX4 IFI27L2 BEND4 APOL4 GRIP2	9.60e-05	192	106	5	bcc499f4c7ba2898ecd9c47bf68c92ed359b81ba
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHCG SOX4 SGMS2 TSC22D2 CADPS2	9.60e-05	192	106	5	6fb56d062c35617b18b927704bf5fba894faed81
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)\|368C / Donor, Lineage, Cell class and subclass (all cells)	ACTA1 ACTA2 ACTC1 ACTG2 ACAN	9.84e-05	193	106	5	5182284dfa7c94027e94172e08f78c86b95d63f4
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 SCN3A GRIP2 PLCE1	9.84e-05	193	106	5	1043b28503bfaa0d5a82ec358bc86cbde73ea8f2
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ACTA1 ACTA2 ACTC1 ACTG2 ACAN	9.84e-05	193	106	5	5260ac95a15cc43a19909badad0c7e3854da920d
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB CAD PREB ENTPD3 HSPA5	9.84e-05	193	106	5	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTC1 ACTG2 ACAN GRIP2	9.84e-05	193	106	5	800b0f5705fefcd3608e37801afae8a94474723e
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 SCN3A GRIP2 PLCE1	9.84e-05	193	106	5	0266a4fdf436d83ec1d9392abba8c6ec5166970a
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ACTA1 ACTA2 ACTC1 ACTG2 ACAN	9.84e-05	193	106	5	5ec917931b438dd0e7fb03eb6af459d3ef6b84ba
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	ACTA1 ACTA2 ACTC1 ACTG2 ACAN	9.84e-05	193	106	5	4f7bab0115469c855160636d168bd6e5d4e2dd2f
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA2 ACTC1 ACAN SCN3A ENTPD3	1.01e-04	194	106	5	5099e6ad7c19e5f8b73449d904aaefd97f1b1959
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA2 ACTC1 ACAN SCN3A ENTPD3	1.01e-04	194	106	5	71734ef7b34ab33b349595368176fa0e1175d4d0
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTA2 ACTG2 ACAN ENTPD3 GRIP2	1.03e-04	195	106	5	5dc874641ad9537e4c1369825c1fb0a59f12a83d
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTC1 ACTG2 ACAN GRIP2	1.03e-04	195	106	5	c51b1bee79e77aa2ac444a4883ef533c0095eaad
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTC1 ACTG2 ACAN GRIP2	1.03e-04	195	106	5	43d372373367b71243c6ea958aedccde4478618f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA2 ACTG2 CADPS ACAN EPB41L2	1.06e-04	196	106	5	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	11.5-Distal-Mesenchymal-Airway_Smooth_Muscle\|Distal / Age, Tissue, Lineage and Cell class	RHCG SOX4 ACTA2 ACTG2 TLE2	1.06e-04	196	106	5	05530fe7a5681c2f39b95016cd22ef99d6ac0430
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPR3 OVCH1 SLC5A4 GRIP2 HYAL2	1.06e-04	196	106	5	915e4a7422058be246b54760df31e8a607310625
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA2 ACTG2 CADPS ACAN EPB41L2	1.06e-04	196	106	5	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADGRV1 FAAH PKHD1 CADPS2 HSPA5	1.08e-04	197	106	5	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTA2 ACTC1 ACTG2 ACAN ENTPD3	1.08e-04	197	106	5	cc494a656db868bb489238a5becc31bc8518f3cc
ToppCell	5'-GW_trimst-1.5-LargeIntestine\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX4 ACTA2 ACTC1 ACTG2 HSPA5	1.08e-04	197	106	5	0b2ad6a933ff1a325649cc8f139380fd158a1d42
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX4 ACTA2 ACTC1 ACTG2 HSPA5	1.08e-04	197	106	5	5f6fce382f273e789ffbb75b63e9b4e87519918e
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTA2 ACTC1 ACTG2 ENTPD3 GRIP2	1.08e-04	197	106	5	d16bb765afdc02406ffd7ce6a75bae72b66db66c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTA2 ACTC1 ACTG2 ENTPD3 GRIP2	1.08e-04	197	106	5	68c23c23b6924892f4c238cf2f5abc7927e04fbc
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA2 ACTC1 ACAN SCN3A ENTPD3	1.11e-04	198	106	5	77288df94286382170a266474ab85960519e8449
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA2 ACTC1 ACAN SCN3A ENTPD3	1.11e-04	198	106	5	2ee195f20a4f91fa1dcad9eaf96d6086e3b0fb4a
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	SOX4 SPOCK1 TLE5 TLE2 GRIP2	1.11e-04	198	106	5	076c862f2a723f0361749377561cae902068b1a0
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SOX4 FLNB ADGRV1 PLEKHG4B WDR86	1.11e-04	198	106	5	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOX4 NPR3 BEND4 HSPA5 EPB41L2	1.14e-04	199	106	5	01ab0363558f215f9979e20fd5170d8fee149cea
Computational	Muscle genes.	ACTA1 ACTA2 ACTC1 ACTG2	6.92e-05	37	65	4	MODULE_512
Computational	Genes in the cancer module 387.	ACTA1 ACTA2 ACTC1 ACTG2	2.10e-04	49	65	4	MODULE_387
Computational	Genes in the cancer module 329.	ACTA1 ACTA2 ACTC1 ACTG2	2.46e-04	51	65	4	MODULE_329
Drug	CID5288653	FLNB ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	3.96e-11	28	105	7	CID005288653
Drug	Nsc687160	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.48e-10	18	105	6	CID005459290
Drug	tolytoxin	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	2.15e-10	19	105	6	CID006440827
Drug	m2-19	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	2.15e-10	19	105	6	CID000079129
Drug	NSC312786	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	4.27e-10	21	105	6	CID000329495
Drug	AC1L8NVR	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	4.27e-10	21	105	6	CID000384633
Drug	AC1LD8HW	FLNB ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A FH	2.04e-09	75	105	8	CID000644061
Drug	azaspiracid	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	4.52e-09	30	105	6	CID006451158
Drug	triphosphoinositide	SOX4 ACTA1 ACTA2 ACTC1 ACTG2 ASIC3 ACTR1B ACTR1A PI4KB SCN3A EPB41L2 PLCE1	5.03e-09	273	105	12	CID009543520
Drug	AC1L1HS4	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	6.85e-09	32	105	6	CID000004267
Drug	N,N'-p-phenylenedimaleimide	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.01e-08	34	105	6	CID000076765
Drug	1,N6-ethenoadenosine 5'-diphosphate	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.01e-08	34	105	6	CID000001312
Drug	AC1NSKFN	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.45e-08	36	105	6	CID005311324
Drug	sulphoxide	ACTA1 ACTA2 ACTC1 ACTG2 CBS ACTR1B ACTR1A GZMM	2.21e-08	101	105	8	CID000008442
Drug	epsilon-ATP	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	3.28e-08	41	105	6	CID000162262
Drug	caged ATP	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A ENTPD3	3.42e-08	70	105	7	CID000123806
Drug	C3H2N2O3S	FLNB ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	5.06e-08	74	105	7	CID000448652
Drug	AC1L8FNU	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	5.10e-08	44	105	6	CID000425429
Drug	HU-211	ACTA1 ACTA2 ACTC1 ACTG2 CBS ACTR1B ACTR1A TLE5	5.74e-08	114	105	8	CID000107778
Drug	NpCaM	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	8.73e-08	48	105	6	CID000122259
Drug	AC1Q6LQU	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	8.73e-08	48	105	6	CID000072380
Drug	GTP[S]	NPR3 ACTA1 ACTA2 ACTC1 ACTG2 ASIC3 PREB ACTR1B ACTR1A AP1B1 PI4KB SCN3A ENTPD3 PRKAR1A PLCE1	8.86e-08	591	105	15	CID000001764
Drug	AGEPC	ACTA1 ACTA2 PEX6 ACTC1 ACTG2 PEX12 FAAH ACTR1B ACTR1A MS4A2 ENTPD3 PLCE1	9.41e-08	356	105	12	CID000461545
Drug	NSC106399	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.27e-07	51	105	6	CID000002887
Drug	formamide	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A ACAN	1.33e-07	85	105	7	CID000000713
Drug	D-myo-inositol 1,4-bisphosphate	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A PLCE1	1.44e-07	86	105	7	CID000000805
Drug	AC1L1IZ2	ACTA1 ACTA2 MYO18A ACTC1 ACTG2 PFKM ACTR1B ACTR1A GZMM ENTPD3 PRKAR1A	1.64e-07	304	105	11	CID000004795
Drug	enantio-PAF-C16	ACTA1 ACTA2 PEX6 ACTC1 ACTG2 PEX12 ACTR1B ACTR1A ENTPD3 PLCE1	1.97e-07	244	105	10	CID000002499
Drug	AC1NRCMD	ACTA1 ACTA2 ACTC1 ACTG2 IFI27 ACTR1B ACTR1A	1.98e-07	90	105	7	CID005289074
Drug	3-methylhistidine	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	2.01e-07	55	105	6	CID000064969
Drug	mDia	FLNB ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	2.48e-07	93	105	7	CID000128346
Drug	dihydrocytochalasin B	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	2.77e-07	58	105	6	CID000003064
Drug	Rp-cAMPS	NPR3 ACTA1 ACTA2 ACTC1 ACTG2 SLC5A11 ACTR1B ACTR1A PRKAR1A	2.92e-07	194	105	9	CID006426631
Drug	oryzalin	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	4.57e-07	63	105	6	CID000029393
Drug	beryllium fluoride	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A WDFY3	4.99e-07	103	105	7	CID000024589
Drug	bumetanide	RHCG ACTA1 ACTA2 ACTC1 ACTG2 SLC5A4 SLC5A11 ACTR1B ACTR1A	5.47e-07	209	105	9	CID000002471
Drug	AC1Q5THZ	NPR3 ACTA1 ACTA2 ACTC1 ACTG2 NDUFA9 ACTR1B ACTR1A MS4A2 ENTPD3 PRKAR1A HSPA5 PLCE1	5.49e-07	502	105	13	CID000001959
Drug	DL-arginine	NPR3 ACTA1 ACTA2 ACTC1 ACTG2 CBS ACTR1B ACTR1A SLC7A1 SLC7A3 TLE5	5.61e-07	344	105	11	CID000000232
Drug	5-IAF	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	6.05e-07	66	105	6	CID000123822
Drug	MgCl2	HYAL4 ACTA1 ACTA2 MYO18A ACTC1 ACTG2 PFKM ACTR1B ACTR1A ENTPD3 HYAL2	7.44e-07	354	105	11	CID000024584
Drug	AC1LCVPZ	SPOCK1 ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	7.81e-07	110	105	7	CID000656926
Drug	Ro-1724	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A PRKAR1A	7.81e-07	110	105	7	CID000005087
Drug	AC1L1ERT	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	7.89e-07	69	105	6	CID000002920
Drug	AC1MNW2N	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	8.60e-07	70	105	6	CID003359490
Drug	L-Carnosine	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.10e-06	73	105	6	CID000009369
Drug	blebbistatin	ACTA1 ACTA2 MYO18A ACTC1 ACTG2 ACTR1B ACTR1A	1.12e-06	116	105	7	CID003476986
Drug	B0683	ACTA1 ACTA2 MYO18A ACTC1 ACTG2 ACTR1B ACTR1A	1.19e-06	117	105	7	CID006398969
Drug	SIRIUS	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.51e-06	77	105	6	CID000091750
Drug	serotonin	NPR3 ACTA1 ACTA2 ACTC1 ACTG2 MPDZ PFKM ACTR1B ACTR1A ACAN ENTPD3 HTT PLCE1	1.65e-06	554	105	13	CID000005202
Drug	AC1L9EF8	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.76e-06	79	105	6	CID000443315
Drug	quinacrine	ACTA1 ACTA2 ACTC1 ACTG2 CBS SLC5A4 SLC5A11 ACTR1B ACTR1A	1.91e-06	243	105	9	CID000000237
Drug	D-myo-inositol-1,4,5-triphosphate	ACTA1 ACTA2 ACTC1 ACTG2 PFKM ACTR1B ACTR1A MS4A2 PI4KB ENTPD3 PRKAR1A HTT PLCE1	2.17e-06	568	105	13	CID000000806
Drug	6-trans-leukotriene B4	ACTA1 ACTA2 PEX6 ACTC1 ACTG2 PEX12 ACTR1B ACTR1A PLCE1	2.19e-06	247	105	9	CID000000169
Drug	plakin	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	2.20e-06	82	105	6	CID000018752
Drug	lithium aluminum hydride	ACTA1 ACTA2 ACTC1 ACTG2 SLC5A11 ACTR1B ACTR1A SCN3A HSD17B10 PLCE1	2.32e-06	320	105	10	CID000028112
Drug	AC1MU1S9	NPR3 NRF1 ACTA1 ACTA2 ACTC1 ACTG2 FAAH ACTR1B ACTR1A MS4A2 PRKAR1A HSPA5 PLCE1	2.34e-06	572	105	13	CID000003733
Drug	NSC613009	ACTA1 ACTA2 ACTC1 ACTG2 CBS ACTR1B ACTR1A	2.41e-06	130	105	7	CID000003800
Drug	AC1NST48	SPOCK1 ACTA1 ACTA2 ACTC1 ACTG2 PREB ACTR1B ACTR1A AP1B1 ACAN ENTPD3 PRKAR1A HSPA5	3.54e-06	594	105	13	CID005315496
Drug	acetaldehyde	ACTA1 ACTA2 ACTC1 ACTG2 SPAG9 CBS ACTR1B ACTR1A MS4A2 FH	3.77e-06	338	105	10	CID000000177
Drug	AC1L22RD	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	4.04e-06	91	105	6	CID000065183
Drug	0-to	ACTA1 ACTA2 ACTC1 ACTG2 IFI27 ACTR1B ACTR1A	4.13e-06	141	105	7	CID000002051
Drug	C18:1n-7	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	4.31e-06	92	105	6	CID000122325
Drug	cnicin	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	4.31e-06	92	105	6	CID000091176
Drug	AC1OAGGW	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A PI4KB EPB41L2	4.63e-06	203	105	8	CID006857364
Drug	AC1L1GXW	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	4.88e-06	94	105	6	CID000003891
Drug	candesartan cilexetil	ACTA1 ACTA2 MYO18A ACTC1 ACTG2 ACTR1B ACTR1A	4.97e-06	145	105	7	CID000002540
Drug	nitroglycerin	NPR3 ACTA1 ACTA2 ACTC1 ACTG2 CBS ACTR1B ACTR1A	5.16e-06	206	105	8	CID000004510
Drug	manidipine	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	5.19e-06	95	105	6	CID000004008
Drug	PI(3,4,5)P3	ACTA1 ACTA2 ACTC1 ACTG2 IFI27 ACTR1B ACTR1A	5.69e-06	148	105	7	CID000643963
Drug	NSC3096	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	6.22e-06	98	105	6	CID000002832
Drug	fasudil	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A PRKAR1A	6.49e-06	151	105	7	CID000003547
Drug	carbodiimide	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A PRKAR1A	6.49e-06	151	105	7	CID000009864
Drug	AC1OAGFB	ACTA1 ACTA2 PEX6 ACTC1 ACTG2 ASIC3 ACTR1B ACTR1A PI4KB SCN3A EPB41L2 PLCE1	7.25e-06	539	105	12	CID006857345
Drug	CaCl2	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A ENTPD3	8.04e-06	156	105	7	CID000024854
Drug	dl-Lysine	ACTA1 ACTA2 ACTC1 ACTG2 SLC7A14 ACTR1B ACTR1A SLC7A1 SLC7A3	8.05e-06	290	105	9	CID000000866
Drug	etheno-NAD	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	8.77e-06	104	105	6	CID005288160
Drug	polyproline	FLNB ACTA1 ACTA2 ACTC1 ACTG2 PFKM ACTR1B ACTR1A HTT	9.23e-06	295	105	9	CID000439587
Drug	ATP betaS	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A ENTPD3	1.03e-05	162	105	7	CID005311341
Drug	NSC-351907	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A PI4KB PLCE1	1.12e-05	229	105	8	CID000004016
Drug	AC1L2DAI	ACTA1 ACTA2 ACTC1 ACTG2 DDOST ACTR1B FCSK ACTR1A HSPA5	1.17e-05	304	105	9	CID000004984
Drug	(2S,3R)-Sphingosine	ACTA1 ACTA2 ACTC1 ACTG2 PFKM ACTR1B ACTR1A PI4KB PRKAR1A PLCE1	1.29e-05	389	105	10	CID000001104
Drug	khellin	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A SLC39A6	1.46e-05	171	105	7	CID000003828
Drug	Formyl	ACTA1 ACTA2 ACTC1 ACTG2 CBS ACTR1B ACTR1A PLCE1	1.48e-05	238	105	8	CID000123370
Drug	AC1L1BDQ	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A PRKAR1A	1.58e-05	173	105	7	CID000001394
Drug	1tjp	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.64e-05	116	105	6	CID005459371
Drug	indomethacin	NPR3 ACTA1 ACTA2 ACTC1 ACTG2 CBS FAAH ACTR1B ACTR1A ACAN ENTPD3 PRKAR1A HSD17B10	1.75e-05	690	105	13	CID000003715
Drug	Co-protoporphyrin IX	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.81e-05	118	105	6	CID000004972
Drug	Pb m	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.81e-05	118	105	6	CID006327255
Drug	protocatechuic acid	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.90e-05	119	105	6	CID000000072
Drug	TCNB	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	1.90e-05	119	105	6	CID000008330
Drug	trifluoperazine	ACTA1 ACTA2 MYO18A ACTC1 ACTG2 PFKM ACTR1B ACTR1A PRKAR1A	1.94e-05	324	105	9	CID000005566
Drug	NSC339663	ACTA1 ACTA2 MYO18A ACTC1 ACTG2 CBS ACTR1B ACTR1A	2.11e-05	250	105	8	CID000003892
Drug	ammonia	RHCG CAD ACTA1 ACTA2 ACTC1 ACTG2 PFKM CBS ACTR1B ACTR1A FH	2.35e-05	509	105	11	CID000000222
Drug	N-ethylmaleimide	ACTA1 ACTA2 MYO18A ACTC1 ACTG2 ACTR1B ACTR1A SLC7A1 SLC7A3 ENTPD3 APOL4	2.43e-05	511	105	11	CID000004362
Drug	Dioxins	ACTA1 ACTA2 PSMC5 ADGRV1 TEX10 PTER CBS DDOST GTF2H4 TLE5 PI4KB SLC39A6 HSD17B10 HSPA5 HTT	2.48e-05	934	105	15	ctd:D004147
Drug	2C5P	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	2.74e-05	127	105	6	CID000447961
Drug	sodium	ACTA1 ACTA2 ACTC1 ACTG2 ASIC3 SLC7A14 SLC5A4 SLC5A11 ACTR1B ACTR1A SLC7A1 SLC7A3 SCN3A PRKAR1A HSD17B10	2.80e-05	944	105	15	CID000000923
Drug	sodium nitroprusside	NPR3 ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A PRKAR1A	2.86e-05	261	105	8	CID000045469
Drug	MAPS	SOX4 ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	2.98e-05	191	105	7	CID000066161
Drug	microcystin-LR	ACTA1 ACTA2 ACTC1 ACTG2 ACTR1B ACTR1A	2.99e-05	129	105	6	CID000445433
Disease	autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	8.96e-09	8	101	4	DOID:0110550 (implicated_via_orthology)
Disease	Baraitser-Winter syndrome 1 (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	8.96e-09	8	101	4	DOID:0081112 (implicated_via_orthology)
Disease	Moyamoya disease (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	8.96e-09	8	101	4	DOID:13099 (implicated_via_orthology)
Disease	thoracic aortic aneurysm (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	8.96e-09	8	101	4	DOID:14004 (implicated_via_orthology)
Disease	intestinal atresia (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	2.67e-08	10	101	4	DOID:10486 (implicated_via_orthology)
Disease	patent ductus arteriosus (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	2.67e-08	10	101	4	DOID:13832 (implicated_via_orthology)
Disease	Peroxisome biogenesis disorder	PEX6 PEX12	3.47e-05	3	101	2	cv:C1832200
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	TSC22D2 TEX10 ACAN PKHD1 COASY HTT PLCE1	2.61e-04	364	101	7	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	low tension glaucoma	FLNB TMEM263	4.11e-04	9	101	2	EFO_1001022
Disease	creativity measurement	SLC16A9 EPB41L2	5.13e-04	10	101	2	EFO_0010650
Disease	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	PEX6 PEX12	6.25e-04	11	101	2	C4721541
Disease	Akinetic-Rigid Variant of Huntington Disease	FAAH HTT	7.49e-04	12	101	2	C0751207
Disease	Juvenile Huntington Disease	FAAH HTT	7.49e-04	12	101	2	C0751208
Disease	Huntington Disease, Late Onset	FAAH HTT	7.49e-04	12	101	2	C0393574
Disease	Zellweger Spectrum	PEX6 PEX12	8.83e-04	13	101	2	C3658299
Disease	Infantile Refsum Disease (disorder)	PEX6 PEX12	8.83e-04	13	101	2	C0282527
Disease	Zellweger-Like Syndrome	PEX6 PEX12	8.83e-04	13	101	2	C0751594
Disease	receptive language perception, parental genotype effect measurement	MUC19 ACTG2	1.03e-03	14	101	2	EFO_0005686, EFO_0005939
Disease	sulfate measurement	CADPS2 HTT	1.03e-03	14	101	2	EFO_0007864
Disease	Peroxisome biogenesis disorders	PEX6 PEX12	1.18e-03	15	101	2	C1832200
Disease	Adrenoleukodystrophy, Neonatal	PEX6 PEX12	1.18e-03	15	101	2	C0282525
Disease	hearing threshold measurement, hearing measurement	SLC16A9 MYO18A SLC7A14	1.21e-03	61	101	3	EFO_0007616, EFO_0007618
Disease	preeclampsia, hypertension, pregnancy-induced	NPR3 PLCE1	1.35e-03	16	101	2	EFO_0000668, MONDO_0024664
Disease	Zellweger Syndrome	PEX6 PEX12	1.35e-03	16	101	2	C0043459
Disease	body fat percentage	TSC22D2 TEX10 ACAN PKHD1 COASY HTT PLCE1	1.47e-03	488	101	7	EFO_0007800
Disease	Huntington Disease	FAAH HTT	1.53e-03	17	101	2	C0020179
Disease	Disproportionate short stature	FLNB ACAN PRKAR1A	2.37e-03	77	101	3	C0878659
Disease	Huntington's disease (is_implicated_in)	NRF1 HTT	2.80e-03	23	101	2	DOID:12858 (is_implicated_in)
Disease	comparative body size at age 10, self-reported	RHCG TTBK1 CADPS ACAN PKHD1 PRKAR1A	3.27e-03	420	101	6	EFO_0009819

Protein segments in the cluster

Peptide	Gene	Start	Entry
IDSIGSSRLEGGSGG	PSMC5	251	P62195
LGANTASSIAGGTGI	MS4A2	131	Q01362
LGLGSAVSLTICGAG	MS4A2	191	Q01362
VGLGLSASTVALGTG	nan	396	Q9N2K0
ASGRTTGIVLDSGDG	ACTA1	146	P68133
GLSLSITAAGVGLGI	APOL4	166	Q9BPW4
ITAAGVGLGIASATA	APOL4	171	Q9BPW4
GGVLTGLSGVLTSPE	CDCP2	146	Q5VXM1
LSVGSSFGTQIIGGR	GZMM	16	P51124
AGTGGTGSDSASLEL	BEND4	146	Q6ZU67
GRTTGVVLDSGDGVT	ACTR1B	151	P42025
VQLTDASGGGTIGLD	ADGRV1	2321	Q8WXG9
ASGRTTGIVLDSGDG	ACTA2	146	P62736
GGSSRGGTAILLLTG	CAMTA2	316	O94983
SGRTTGIVLDSGDGV	ACTG2	146	P63267
GSGLSDLFDLTSGVG	AP1B1	696	Q10567
GLELGSGVTVSSGQG	DENND1C	146	Q8IV53
GREAATSTLGGLGFS	BCOR	101	Q6W2J9
SGGLEESAVTGIVVG	NPR3	476	P17342
GVETTGALDLGGAST	ENTPD3	211	O75355
LGLGLGGRSAASSSV	MSANTD2	66	Q6P1R3
SSSEANGTGLELLGG	KCNH3	431	Q9ULD8
LSSAGSGLIGDVDEG	SPAG9	386	O60271
VTIFGGSVGGESVSV	CES1P1	216	Q9UKY3
EATASVSEGGGLQGI	CADPS	1326	Q9ULU8
GTTLSGVDLELVGSG	FCHO1	856	O14526
RGLALGLISTGSSVG	SLC16A9	136	Q7RTY1
IANGGGVASGSLVAT	IFI27	76	P40305
ISTIGESAALGAAGV	HYAL2	311	Q12891
GGGVSAGSLVATLQS	IFI27L2	51	Q9H2X8
SGGGGSSATDLVFLI	MATN1	266	P21941
VSLGGDGAEAITGLT	ATXN1L	61	P0C7T5
STGTVLGAGSIGTDI	ARNTL2	506	Q8WYA1
IDGGAGGDSGTLLTA	EPB41L2	911	O43491
SGDGLADITVGTLGQ	ITGAE	656	P38570
TVLELGSGAGLTGLA	FAM86B1	126	Q8N7N1
GTGLEGGTTGIQSEF	FLNB	2391	O75369
LIGSGTTGLSAEATG	MUC19	3071	Q7Z5P9
AGITGTNGLSAEVTG	MUC19	3301	Q7Z5P9
AGVTRTTGLSAGETG	MUC19	3331	Q7Z5P9
AGVTGTTELSAGVTG	MUC19	3411	Q7Z5P9
AGVAGTTRLSAGVTG	MUC19	3521	Q7Z5P9
TEPLAGGTGTTGILA	MUC19	3636	Q7Z5P9
TGILAGVTGTTGLSA	MUC19	3646	Q7Z5P9
EVTGKTGLSAGVTGT	MUC19	3691	Q7Z5P9
TGLSAGVTGIAGLSA	MUC19	3776	Q7Z5P9
GVTGIAGLSAGVTGI	MUC19	3781	Q7Z5P9
GVTGSTGLLAGVTET	MUC19	3881	Q7Z5P9
GLSAEVTGTTGLSVG	MUC19	3946	Q7Z5P9
GLSVGVTGIAGLSAG	MUC19	3956	Q7Z5P9
VTGIAGLSAGVTGIT	MUC19	3961	Q7Z5P9
GLSAEATGITGLSAG	MUC19	3996	Q7Z5P9
GLSAGVTGTTGLSTE	MUC19	4056	Q7Z5P9
GLSAGVTGITGLSAI	MUC19	4086	Q7Z5P9
TGTNGLSAEVTGTIG	MUC19	4141	Q7Z5P9
LSAEVTGTIGPLAGG	MUC19	4146	Q7Z5P9
LSAGVTGTIGLSAGV	MUC19	4306	Q7Z5P9
LAGVTGTTGISAGVT	MUC19	4466	Q7Z5P9
GTIGSSAVVTGINGL	MUC19	4491	Q7Z5P9
SGGVTGTNGLSAEVT	MUC19	4556	Q7Z5P9
GITGLSAEVTGTTGL	MUC19	4611	Q7Z5P9
GIAGLSAGVTETIGS	MUC19	4631	Q7Z5P9
ETIGSSAGVTGTNGL	MUC19	4641	Q7Z5P9
ESTGLSAGVTGTTGL	MUC19	4691	Q7Z5P9
LAGVTGTIGLSAGVT	MUC19	4736	Q7Z5P9
GTIGLSAGVTGIAGL	MUC19	4741	Q7Z5P9
SAGVTGIAGLSAGVT	MUC19	4746	Q7Z5P9
GIAGLSAGVTESTGL	MUC19	4751	Q7Z5P9
GISGLSAEVTGTTGL	MUC19	4871	Q7Z5P9
ETIGSSAGVTGTNGL	MUC19	4891	Q7Z5P9
SAGIAGTNGLSAGVT	MUC19	4936	Q7Z5P9
GTTGSLAEVTGTTGL	MUC19	5011	Q7Z5P9
LAGVTGTTGLSAGVT	MUC19	5066	Q7Z5P9
GTNGLSAEVTGTTGL	MUC19	5321	Q7Z5P9
GISGLSAEVTGTTGL	MUC19	5531	Q7Z5P9
ETIGLSAGVTGTIGS	MUC19	5611	Q7Z5P9
GTIGSSAGVTEITGL	MUC19	5621	Q7Z5P9
SAGVTGIAGLSAGVT	MUC19	5686	Q7Z5P9
EITGLSAGVTGTTGL	MUC19	5731	Q7Z5P9
SAGVTGIAGLSAGVT	MUC19	5746	Q7Z5P9
GIAGLSAGVTETIGS	MUC19	5751	Q7Z5P9
ETIGSSAGVTGTNGL	MUC19	5761	Q7Z5P9
GTTGLSAGVTETIGL	MUC19	5801	Q7Z5P9
ETIGLSAGVTGTIGS	MUC19	5811	Q7Z5P9
SGGVTGITGLSAGLR	MUC19	5856	Q7Z5P9
GITGLSAGLRGTTVS	MUC19	5861	Q7Z5P9
AGVTGIAALSAGVTG	MUC19	5976	Q7Z5P9
AEVTGTTGLSAGVIG	MUC19	6036	Q7Z5P9
AGVIGTTGSSAEVTG	MUC19	6046	Q7Z5P9
AEVTGITGLSAGVTG	MUC19	6056	Q7Z5P9
LGVSGTTSVGRATGA	MUC19	6431	Q7Z5P9
LGVSGTTNIGRATGA	MUC19	6791	Q7Z5P9
TTSLGGSGTTGAEIK	MUC19	6991	Q7Z5P9
TTTSLEGGGTTGAEI	MUC19	7431	Q7Z5P9
GRAGSATVLSGSIAG	MYO18A	976	Q92614
ATVLSGSIAGLEGGS	MYO18A	981	Q92614
IGGDGSLTGADTFRS	PFKM	116	P08237
GVLGGTGDSLGVSRS	PEX6	196	Q13608
GGALLTGTSSVLLRG	PEX6	456	Q13608
LSGETAAAVGALTGV	NRF1	431	Q16656
SGADGAELLTTTRGG	ASIC3	191	Q9UHC3
DGGGSVLVAASSDIG	DDOST	121	P39656
VGAVVCSIAGSSLGG	MFSD3	256	Q96ES6
GGRSSVSGIVATVFG	NDUFA9	46	Q16795
TGGASGLGLATAERL	HSD17B10	16	Q99714
GLGVSGSTLTFQEGE	ACAN	2146	P16112
TGGGNIVVATADGSS	MED16	221	Q9Y2X0
GGGALVENTTTGISR	PTER	91	Q96BW5
GELGVGLGDGSISLS	DCHS2	456	Q6V1P9
HGSGLGTSSILAGTA	FCSK	836	Q8N0W3
RSGSIVELIAGGGSS	HTT	416	P42858
EDGTLGFSVTGGINT	FRMPD2	956	Q68DX3
ELAAGGTAVGTGLNT	FH	271	P07954
LVSTIGESAALGAAG	HYAL4	321	Q2M3T9
LVASVGTGGTITGIA	CBS	251	P35520
GRTTGVVLDSGDGVT	ACTR1A	151	P61163
EATASVSEGGGLQGI	CADPS2	1271	Q86UW7
ATSVGEGGSFGELAL	PRKAR1A	191	P10644
VLGDGGNSSLTISEG	AHCTF1	1456	Q8WYP5
TSVSALSGATAGILG	EMC6	31	Q9BV81
ALETLSTGGLFSDGG	FAAH	371	O00519
GSTLGLTISGGTDKD	GRIP2	56	Q9C0E4
GGGTFDVSLLTIDNG	HSPA5	226	P11021
DLVALGVGSTLGAGV	SLC7A3	36	Q8WY07
STSIGVGTEGGTNLA	FAM126B	466	Q8IXS8
AGESSDSGAGLELGI	SOX4	16	Q06945
TAERDSGLGATGGSV	TSC22D2	211	O75157
IGSVLGALIGVAGST	CCDC51	206	Q96ER9
GTGIESTSLGIFGVG	PLCE1	1311	Q9P212
GSGCGSLAILVEEGT	OVCH1	416	Q7RTY7
GDGTVSTVLGNGSSL	SIGLEC9	246	Q9Y336
GLAGTGAASGVATVT	SLC5A4	86	Q9NY91
GLAGSGAATGISVSA	SLC5A11	86	Q8WWX8
GSLLGGTILSISGIG	PKHD1	1206	P08F94
DFSGIGGLGELLESS	SCN3A	471	Q9NY46
SFGSGLLESSGVIVG	SEC31B	76	Q9NQW1
ELGAGTGLASIIAAT	METTL22	211	Q9BUU2
LISGGGLSITGSHIL	SGMS2	206	Q8NHU3
LSTRSGGVGVNLTGA	SRCAP	2116	Q6ZRS2
GGVALSLSTGLSVGV	PEX12	241	O00623
GGSLLSVITEGVGEL	PI4KB	26	Q9UBF8
GSVASLSVGEGTGVR	OSER1	26	Q9NX31
GLAIGAAFTEGLSSG	SLC39A6	611	Q13433
SGGLAGSEGTAGLDV	SLX4	631	Q8IY92
GVSAVAGGVTAVGSA	TMEM263	86	Q8WUH6
ASGRTTGIVLDSGDG	ACTC1	146	P68032
IGLTGISGSGKSSIA	COASY	361	Q13057
LAINLSSGVSGAGGT	GTF2H4	286	Q92759
AVSAGTGLLSLSALG	TLE5	156	Q08117
VDLISLGVGSCVGTG	SLC7A14	56	Q8TBB6
SGTFLGLGTVTGSVA	PREB	311	Q9HCU5
IDSGGLIGGALTSAG	URGCP	751	Q8TCY9
GLLQGTSAETSGGLL	SEPHS2	361	Q99611
SGLNGAEIEGSALSG	TTBK1	986	Q5TCY1
TGLIDGAVVSGIGSG	WDFY3	1076	Q8IZQ1
GGLGIAISEEDTLSG	MPDZ	1491	O75970
RTGLGLSIVGGSDTL	MPDZ	1636	O75970
VTGIVDGSGSIGAAV	SLC37A3	426	Q8NCC5
LGILAGTGTGIAGIT	ERVFRD-1	361	P60508
GTGTGIAGITKASLT	ERVFRD-1	366	P60508
DLVALGVGSTLGAGV	SLC7A1	36	P30825
TGASRDLGTGAVASG	PLEKHG4B	26	Q96PX9
ETSGDFGSGGSVVLL	SPOCK1	381	Q08629
VGGLSGVDEGLSSTE	TEX10	301	Q9NXF1
GASSENAGTLGTVAG	CAD	1536	P27708
NAGTLGTVAGSAAGL	CAD	1541	P27708
GGIVGAVTAASASLE	RHCG	351	Q9UBD6
SSALASLTGLGGLGG	PNISR	376	Q8TF01
VGGSATGLLALSGAL	TLE2	146	Q04725
AAGGLLVTGSTDGTA	WDR86	161	Q86TI4
TSRLLSVGGEAFSGG	TMEM25	76	Q86YD3
LSGSSAGGILAAGVF	TMEM260	116	Q9NX78